Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

Medications for PCOS don't seem to raise heart disease risk.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Ayurvedic treatment can effectively manage PCOS and its symptoms.

Women with PCOS have more emotional and body image issues than healthy women.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.